Atlas Trials

Study of GBT021601 in Participants With Renal Impairment

Clinical trial NCT05878704 · TERMINATED

Trial details

NCT number
NCT05878704
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2023-06-29
Primary completion
2024-07-29
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.